Purinergic P2X Receptor Antagonists [purinergní receptory P2X - antagonisté]
- Terms
-
purinergní receptory P2X1 - antagonisté
purinergní receptory P2X2 - antagonisté
purinergní receptory P2X3 - antagonisté
purinergní receptory P2X4 - antagonisté
purinergní receptory P2X5 - antagonisté
purinergní receptory P2X6 - antagonisté
purinergní receptory P2X7 - antagonisté
purinoceptory P2X - antagonisté
-
P2X Purinoceptor Antagonists
P2X1 Purinoceptor Antagonists
P2X2 Purinoceptor Antagonists
P2X3 Purinoceptor Antagonists
P2X4 Purinoceptor Antagonists
P2X5 Purinoceptor Antagonists
P2X6 Purinoceptor Antagonists
P2X7 Purinoceptor Antagonists
Purinergic P2X1 Receptor Antagonists
Purinergic P2X2 Receptor Antagonists
Purinergic P2X3 Receptor Antagonists
Purinergic P2X4 Receptor Antagonists
Purinergic P2X5 Receptor Antagonists
Purinergic P2X6 Receptor Antagonists
Purinergic P2X7 Receptor Antagonists
Compounds that bind to and block the stimulation of PURINERGIC P2X RECEPTORS. Included under this heading are antagonists for specific P2X receptor subtypes.
- DUI
- D058920 MeSH Browser
- CUI
- M0545369
- Previous indexing
- Receptors, Purinergic P2/antagonists & inhibitors (1994-2010)
- History note
- 2011
- Public note
- 2011
Allowable subheadings
- AD
- administration & dosage 0
- AE
- adverse effects 0
- AN
- analysis 0
- BL
- blood 0
- CF
- cerebrospinal fluid 0
- CS
- chemical synthesis 0
- CH
- chemistry 0
- CL
- classification 0
- EC
- economics 0
- HI
- history 0
- IM
- immunology 0
- IP
- isolation & purification 0
- ME
- metabolism 0
- PK
- pharmacokinetics 0
- PD
- pharmacology 1
- PO
- poisoning 0
- RE
- radiation effects 0
- ST
- standards 0
- SD
- supply & distribution 0
- TU
- therapeutic use 0
- TO
- toxicity 0
- UR
- urine 0